Hormonal

Follistatin

Also known as: FST, FS344, FS315

Clinical Trials
Share:

Buy in shop

Follistatin from $368/kit

2 verified vendors, ≥99% purity, COAs included.

Compare prices

Key Facts: Follistatin

Category
Hormonal
FDA Status
Not FDA Approved
Clinical Status
Investigational - Gene therapy trials
Administration
Subcutaneous injection
Typical Dose
Limited community data available
Frequency
See research protocols
Duration
Variable protocols
Also Known As
FST, FS344, FS315

Mechanism of Action

Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as an endogenous off-switch on muscle growth, signaling through activin type II receptors. Follistatin binds and sequesters myostatin (and related ligands like certain activins) so they cannot dock on their receptors, effectively releasing the brake and allowing muscle fibers to enlarge. By neutralizing several TGF-beta family members at once, follistatin can drive more muscle hypertrophy in animal models than narrower myostatin blockers. The hypothesis behind the therapy is straightforward: more free follistatin means less active myostatin means bigger, less fibrotic muscle.

Research Summary

The strongest human data comes from a Phase 1/2a gene therapy trial using AAV1.CMV.FS344 injected directly into the quadriceps of six men with Becker muscular dystrophy, published in Molecular Therapy in 2015. Several patients improved on the 6-minute walk test, by roughly 58 to 125 meters in one cohort, while one or two showed no benefit, and muscle biopsies showed reduced fibrosis, more normal fiber size, and hypertrophy with no serious adverse effects reported. The same gene-transfer approach was also studied in sporadic inclusion body myositis. This is genuinely promising but still early: tiny sample sizes, an open-label design without a placebo arm, local intramuscular delivery, and no large controlled trials yet confirm a durable functional benefit. It is also worth being blunt that the popular bodybuilding version, injecting follistatin peptide for muscle gains, has essentially no controlled human evidence behind it and is a different thing from the gene therapy studied in patients.

Trial Progress:Preclinical
Pre
I
II
III
IV
FDA

Dosing Information

Human Trials·Human studies conducted, not FDA approved

Typical Dosing

Community experience

Common Dose

Limited community data available

Range

See research dosing

Frequency

See research protocols

Research Dosing

Scientific studies

Doses from research use

Duration

Variable protocols

Administration

Subcutaneous injection

Timing & Administration

Best Time to Take

Morning

Once daily

Food Recommendation

With or without food

Why This Timing?

Follistatin inhibits myostatin. Consistent daily timing supports stable levels.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

  • Muscle soreness
  • Injection site reactions
  • Flu-like symptoms
  • Slight LDL cholesterol increase
  • Potential FSH suppression
  • Product quality concerns (black market)

References

Research This Peptide Further

Buy in shop

Follistatin from $368/kit

2 verified vendors, ≥99% purity, COAs included.

Compare prices

Frequently Asked Questions

What does Follistatin do?

Follistatin is a naturally occurring protein in your body whose claim to fame is shutting down myostatin, the brake that limits how much muscle you can build. Block myostatin and muscle grows, which is why follistatin has been chased hard as a therapy for muscle-wasting diseases and, less responsibly, as a physique-enhancement target. Most of the serious work uses gene therapy that tells muscle to produce follistatin, not injectable follistatin peptide, and nothing here is FDA approved.

How does Follistatin work?

Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as an endogenous off-switch on muscle growth, signaling through activin type II receptors. Follistatin binds and sequesters myostatin (and related ligands like certain activins) so they cannot dock on their receptors, effectively releasing the brake and allowing muscle fibers to enlarge. By neutralizing several TGF-beta family members at once, follistatin can drive more muscle hypertrophy in animal models than narrower myostatin blockers. The hypothesis behind the therapy is straightforward: more free follistatin means less active myostatin means bigger, less fibrotic muscle.

Is Follistatin FDA approved?

No, Follistatin is not currently FDA approved. Current status: Investigational - Gene therapy trials

What are the side effects of Follistatin?

Reported side effects include: Muscle soreness, Injection site reactions, Flu-like symptoms, Slight LDL cholesterol increase, Potential FSH suppression. Individual responses vary based on dosage, duration, and personal health factors.

What is the typical dose of Follistatin?

Community-reported common dose: Limited community data available (See research protocols). Range: See research dosing. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.

Related Peptides

Peptides commonly compared with Follistatin or used in similar applications.

Kisspeptin

Clinical Trials

Kisspeptin is the master switch that tells your brain to start reproduction. It is a family of peptides (the full length is kisspeptin-54, with shorter active fragments KP-14, KP-13, and KP-10) made from the KISS1 gene, and it acts as the upstream trigger for the entire reproductive hormone cascade. It is not an approved drug, but it has been tested in real human trials for fertility, hypothalamic amenorrhea, and male hypogonadism, with promising early results.

Hormonal

MOTS-c

Preclinical

MOTS-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12S rRNA region of mitochondrial DNA and discovered in 2015. It is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. The catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials.

Hormonal

Oxytocin

FDA

Oxytocin is a 9-amino-acid hormone made in the hypothalamus, famous as the chemistry behind labor contractions, breastfeeding, and social bonding. As an injectable drug it is FDA-approved to induce labor and control postpartum bleeding, but the intranasal 'love hormone' versions sold for trust, anxiety, and autism are experimental and the human results are genuinely mixed. The hype runs well ahead of the evidence.

Hormonal

Gonadorelin

FDA

Gonadorelin is a synthetic copy of natural GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) that tells the pituitary to release LH and FSH. It is FDA-approved for evaluating pituitary function and has historical use in inducing ovulation. In the peptide world it is mostly used off-label to keep the testes working during testosterone replacement, and the catch is that timing matters enormously: pulse it and you stimulate, give it continuously and you shut the system down.

Hormonal

Leuprolide

FDA

Leuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide about 20 times more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug, not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.

Hormonal

Desmopressin

FDA

Desmopressin (dDAVP) is a synthetic tweak of the natural hormone vasopressin, redesigned to keep the water-retaining effect while dropping most of the blood-pressure effect. It is a long-established FDA-approved drug used for central diabetes insipidus, bedwetting and nocturia, and certain bleeding disorders like von Willebrand disease and mild hemophilia A. This is settled medicine, not an experimental peptide, and its main real-world danger is straightforward: it can drop your blood sodium dangerously low if you drink too much fluid on it.

Hormonal

Want updates on Follistatin research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.